Sohita Dhillon
#158,308
Most Influential Person Now
Sohita Dhillon's AcademicInfluence.com Rankings
Sohita Dhillonmedical Degrees
Medical
#3142
World Rank
#3597
Historical Rank
Rheumatology
#29
World Rank
#30
Historical Rank
Pharmacology
#376
World Rank
#427
Historical Rank
Sohita Dhillonphilosophy Degrees
Philosophy
#9026
World Rank
#12518
Historical Rank
Logic
#6028
World Rank
#7505
Historical Rank
Download Badge
Medical Philosophy
Sohita Dhillon's Degrees
- PhD Pharmacology University of California, San Francisco
- Doctorate Medicine Stanford University
Why Is Sohita Dhillon Influential?
(Suggest an Edit or Addition)Sohita Dhillon's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Tofacitinib: A Review in Rheumatoid Arthritis (2017) (154)
- Tocilizumab: a review of its use in the management of rheumatoid arthritis. (2009) (148)
- Roxadustat: First Global Approval (2019) (132)
- Epi proColon® 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer (2017) (131)
- Bupropion: a review of its use in the management of major depressive disorder. (2008) (124)
- Atazanavir: a review of its use in the management of HIV-1 infection. (2009) (115)
- Sitagliptin: a review of its use in the management of type 2 diabetes mellitus. (2010) (113)
- Lapatinib (2020) (100)
- Palbociclib: First Global Approval (2015) (95)
- Dinutuximab: First Global Approval (2015) (93)
- Ivosidenib: First Global Approval (2018) (92)
- Teriparatide: a review of its use in osteoporosis. (2008) (80)
- Moxetumomab Pasudotox: First Global Approval (2018) (79)
- Viltolarsen: First Approval (2020) (77)
- Gilteritinib: First Global Approval (2019) (74)
- Eculizumab: A Review in Generalized Myasthenia Gravis (2018) (72)
- Risdiplam: First Approval (2020) (70)
- Safinamide: A Review in Parkinson’s Disease (2017) (70)
- Aducanumab: First Approval (2021) (68)
- Trastuzumab Emtansine: First Global Approval (2013) (63)
- Dapagliflozin: A Review in Type 2 Diabetes (2019) (63)
- Tramadol/Paracetamol Fixed-Dose Combination (2010) (61)
- Avapritinib: First Approval (2020) (57)
- Risperidone: a review of its use in the treatment of irritability associated with autistic disorder in children and adolescents. (2007) (55)
- Regorafenib: A Review in Metastatic Colorectal Cancer (2018) (54)
- Delgocitinib: First Approval (2020) (54)
- Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections (2018) (53)
- Etanercept: a review of its use in the management of rheumatoid arthritis. (2007) (50)
- Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis (2016) (48)
- Fibrin Sealant (Evicel® [Quixil®/Crosseal™]) (2011) (48)
- Orelabrutinib: First Approval (2021) (46)
- Gefitinib: a review of its use in adults with advanced non-small cell lung cancer (2015) (45)
- Tirabrutinib: First Approval (2020) (45)
- Zoledronic acid : a review of its use in the management of bone metastases of malignancy. (2008) (44)
- Semaglutide: First Global Approval (2018) (44)
- Secukinumab: A Review in Ankylosing Spondylitis (2016) (44)
- Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder. (2012) (43)
- Capmatinib: First Approval (2020) (43)
- Ocriplasmin: A Review of Its Use in Patients with Symptomatic Vitreomacular Adhesion (2013) (41)
- Lonafarnib: First Approval (2021) (41)
- Escitalopram: a review of its use in the management of anxiety disorders. (2006) (39)
- Everolimus in Combination with Exemestane: A Review of its Use in the Treatment of Patients with Postmenopausal Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer (2013) (39)
- Ceritinib: First Global Approval (2014) (39)
- Acalabrutinib: First Global Approval (2017) (39)
- Ripretinib: First Approval (2020) (37)
- Ibrutinib: A Review of Its Use in Patients with Mantle Cell Lymphoma or Chronic Lymphocytic Leukaemia (2015) (37)
- Strontium Ranelate (2010) (36)
- Tasimelteon: First Global Approval (2014) (36)
- Bremelanotide: First Approval (2019) (36)
- Trastuzumab Emtansine: A Review of Its Use in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab-Based Therapy (2014) (36)
- Decitabine/Cedazuridine: First Approval (2020) (34)
- Rivastigmine Transdermal Patch (2011) (34)
- Eptinezumab: First Approval (2020) (33)
- Bosentan: a review of its use in the management of digital ulcers associated with systemic sclerosis. (2009) (32)
- Dabrafenib plus Trametinib: a Review in Advanced Melanoma with a BRAFV600 Mutation (2016) (32)
- Isatuximab: First Approval (2020) (31)
- Argatroban: a review of its use in the management of heparin-induced thrombocytopenia. (2009) (31)
- Omega-3 Carboxylic Acids (Epanova®): A Review of Its Use in Patients with Severe Hypertriglyceridemia (2014) (31)
- Alectinib: A Review in Advanced, ALK-Positive NSCLC (2018) (31)
- Bivalent rLP2086 Vaccine (Trumenba®): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10–25 Years (2015) (31)
- Bosentan: a review of its use in the management of mildly symptomatic pulmonary arterial hypertension. (2009) (31)
- Filgotinib: First Approval (2020) (30)
- Trilaciclib: First Approval (2021) (28)
- Beclometasone Dipropionate/Formoterol (2012) (28)
- Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™) (2012) (28)
- Nintedanib: A Review of Its Use as Second-Line Treatment in Adults with Advanced Non-Small Cell Lung Cancer of Adenocarcinoma Histology (2015) (27)
- Intravenous Tocilizumab: A Review of Its Use in Adults with Rheumatoid Arthritis (2014) (26)
- Daprodustat: First Approval (2020) (25)
- Lanreotide Autogel®: A Review of its Use in the Treatment of Patients with Acromegaly (2014) (25)
- Umbralisib: First Approval (2021) (25)
- Efinaconazole: First Global Approval (2013) (24)
- Duloxetine: a review of its use in the management of major depressive disorder in older adults. (2013) (23)
- Ticagrelor: A Review of Its Use in Adults with Acute Coronary Syndromes (2015) (23)
- Tiotropium/Olodaterol: A Review in COPD (2015) (22)
- Bevacizumab: a review of its use in combination with paclitaxel or capecitabine as first-line therapy for HER2-negative metastatic breast cancer. (2011) (22)
- Saxagliptin: A Review in Type 2 Diabetes (2015) (21)
- Live Attenuated Measles, Mumps, Rubella, and Varicella Zoster Virus Vaccine (Priorix-Tetra™) (2008) (21)
- Lazertinib: First Approval (2021) (21)
- Spotlight on Bupropion in Major Depressive Disorder (2008) (20)
- Lurasidone: A Review of Its Use in Adult Patients with Bipolar I Depression (2015) (20)
- Dasatinib: A Review in Pediatric Chronic Myeloid Leukemia (2018) (19)
- Eplerenone: A Review of Its Use in Patients with Chronic Systolic Heart Failure and Mild Symptoms (2013) (19)
- Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler. (2006) (19)
- Zoledronic Acid (2012) (18)
- Telitacicept: First Approval (2021) (17)
- Trifluridine/Tipiracil: A Review in Metastatic Gastric Cancer (2019) (17)
- Meningococcal Quadrivalent Tetanus Toxoid Conjugate Vaccine (MenACWY-TT; Nimenrix®): A Review (2017) (16)
- Certolizumab Pegol: A Review of Its Use in Patients with Axial Spondyloarthritis or Psoriatic Arthritis (2014) (15)
- Tebentafusp: First Approval (2022) (15)
- Spotlight on Risperidone in Irritability Associated with Autistic Disorder in Children and Adolescents (2008) (15)
- Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy. (2011) (14)
- Atezolizumab First-Line Combination Therapy: A Review in Metastatic Nonsquamous NSCLC (2019) (14)
- Collagenase Clostridium Histolyticum: A Review in Peyronie’s Disease (2015) (14)
- Melphalan Flufenamide (Melflufen): First Approval (2021) (13)
- Olverembatinib: First Approval (2022) (13)
- Octocog Alfa, Antihaemophilic Factor (Recombinant), Plasma/Albumin Free Method (Advate®) (2012) (13)
- Bevacizumab Combination Therapy (2012) (12)
- Bevacizumab Combination Therapy: A Review of its Use in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (2013) (12)
- Spotlight on Rivastigmine Transdermal Patch (2011) (12)
- Macitentan: A Review of Its Use in Patients with Pulmonary Arterial Hypertension (2014) (12)
- Armodafinil (2019) (12)
- Hydrocodone Bitartrate ER (Hysingla® ER): A Review in Chronic Pain (2016) (11)
- Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU (2019) (11)
- Capecitabine: in advanced gastric or oesophagogastric cancer. (2007) (10)
- Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa™)† (2010) (10)
- Eslicarbazepine Acetate Monotherapy: A Review in Partial-Onset Seizures (2016) (9)
- Olaparib Tablet: A Review in Ovarian Cancer Maintenance Therapy (2018) (9)
- Clascoterone: First Approval (2020) (8)
- Spotlight on Strontium Ranelate (2010) (8)
- Naproxen/Esomeprazole Fixed-Dose Combination (2011) (8)
- Sugemalimab: First Approval (2022) (8)
- Sutimlimab: First Approval (2022) (8)
- Alteplase: a review of its use in the management of acute ischaemic stroke. (2012) (7)
- Octocog Alfa (Advate®): A Guide to Its Use in Hemophilia A (2012) (7)
- Obinutuzumab: A Review in Rituximab-Refractory or -Relapsed Follicular Lymphoma (2017) (7)
- Penpulimab: First Approval (2021) (6)
- Immune Globulin Subcutaneous (Human) 20% (Hizentra®): A Review in Chronic Inflammatory Demyelinating Polyneuropathy (2019) (6)
- Edoxaban: A Review in Deep Vein Thrombosis and Pulmonary Embolism (2015) (6)
- Ciclesonide Nasal Spray (2012) (6)
- Avalglucosidase alfa: First Approval (2021) (6)
- ABP 980: A Trastuzumab Biosimilar (2018) (5)
- Erlotinib: as maintenance monotherapy in non-small-cell lung cancer. (2011) (5)
- Epi proColon® 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer (2017) (5)
- Saxagliptin (2012) (5)
- Ciclesonide nasal spray: in allergic rhinitis. (2008) (5)
- Fixed-dose naproxen/esomeprazole magnesium: a guide to its use to treat arthritic symptoms and reduce gastric ulcer risk (2012) (4)
- DTPa-HBV-IPV/Hib vaccine (Infanrix hexa™): a guide to its use in infants. (2012) (4)
- Spotlight on Teriparatide in Osteoporosis (2012) (4)
- Phentermine/Topiramate: Pediatric First Approval (2022) (4)
- Fondaparinux: use in thromboprophylaxis of acute medical patients. (2008) (4)
- DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa™): A Guide to Its Use in Infants (2012) (3)
- Correction to: Eculizumab: A Review in Generalized Myasthenia Gravis (2018) (2)
- Carotegrast Methyl: First Approval (2022) (2)
- Desidustat: First Approval (2022) (2)
- Collagenase Clostridium histolyticum in Peyronie’s disease: a guide to its use in the EU (2016) (2)
- Correction to: Aducanumab: First Approval (2021) (2)
- Sodium Thiosulfate: Pediatric First Approval (2022) (2)
- Adagrasib: First Approval (2023) (1)
- Correction to: Trifluridine/Tipiracil: A Review in Metastatic Gastric Cancer (2019) (1)
- Pucotenlimab: First Approval (2022) (1)
- Correction to: Dapagliflozin: A Review in Type 2 Diabetes (2019) (1)
- Correction to: Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU (2019) (1)
- Correction to: Moxetumomab Pasudotox: First Global Approval (2019) (1)
- Correction to: Ivosidenib: First Global Approval (2019) (1)
- Correction to: Lonafarnib: First Approval (2021) (1)
- Nintedanib in advanced NSCLC of adenocarcinoma histology: a profile of its use (2018) (1)
- Erratum to: Dinutuximab: First Global Approval (2015) (1)
- Macitentan: a guide to its use in the treatment of pulmonary arterial hypertension in adults of WHO functional class II or III in the EU (2014) (0)
- Ocriplasmin: a guide to its use in symptomatic vitreomacular adhesion (2014) (0)
- Dosage ANd AAMINIsHATION o s 802 6 Armodafinil : CurrentSFOTUSeeeeetre ete (2018) (0)
- Correction to: Filgotinib: First Approval (2021) (0)
- Correction to: Isatuximab: First Approval (2020) (0)
- Nintedanib in advanced NSCLC of adenocarcinoma histology: a profile of its use (2018) (0)
- Saxagliptin (2020) (0)
- Acknowledgement to Referees (2017) (0)
- Extrafine beclometasone dipropionate/formoterol fumarate metered-dose and dry-powder inhalers in asthma and chronic obstructive pulmonary disease: a profile of their use (2017) (0)
- Eltrombopag in severe aplastic anaemia: a guide to its use in the EU (2016) (0)
- Armodafinil (2022) (0)
- Intravenous Tocilizumab: A Review of Its Use in Adults with Rheumatoid Arthritis (2013) (0)
- Extrafine beclometasone dipropionate/formoterol fumarate metered-dose and dry-powder inhalers in asthma and chronic obstructive pulmonary disease: a profile of their use (2017) (0)
- Bivalent rLP2086 Vaccine (Trumenba®): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10–25 Years (2015) (0)
- Lanreotide Autogel® in acromegaly: a guide to its use in the EU (2015) (0)
- ABP 980: A Trastuzumab Biosimilar (2018) (0)
- Macitentan: a guide to its use in the treatment of pulmonary arterial hypertension in adults of WHO functional class II or III in the EU (2015) (0)
- Octocog alfa (Advate®): a guide to its use in hemophilia A. (2012) (0)
- Correction to: Ripretinib: First Approval (2020) (0)
- Ocriplasmin: a guide to its use in symptomatic vitreomacular adhesion (2014) (0)
- Lanreotide Autogel® in acromegaly: a guide to its use in the EU (2015) (0)
- Bevacizumab Combination Therapy: A Review of its Use in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (2013) (0)
- Collagenase Clostridium histolyticum in Peyronie’s disease: a guide to its use in the EU (2016) (0)
- Correction to: Decitabine/Cedazuridine: First Approval (2020) (0)
- Correction to: Lazertinib: First Approval (2021) (0)
- Correction to: Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections (2018) (0)
- Correction to: Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU (2019) (0)
- Spotlight on Tesamorelin in HIV-Associated Lipodystrophy (2011) (0)
- Eltrombopag in severe aplastic anaemia: a guide to its use in the EU (2016) (0)
This paper list is powered by the following services:
